School of Medicine

The phone network at the Medical Campus and several other School of Medicine and BJC locations will be disrupted for four hours from late Friday, Feb. 19, through early Saturday, Feb. 20, for maintenance.

Research, from Washington University School of Medicine in St. Louis shows that the rate of pot use did not double from 2002 to 2013 — as had been reported in the fall — and that the rate of problems related to the drug remained steady.

Attention Medical Campus drivers: Two southbound lanes of Taylor Avenue between Forest Park and Duncan avenues will be closed from 7 a.m. to 3 p.m. today through Friday, Feb. 12, for construction work.

An upcoming broadcast of NOVA called “Memory Hackers,” airs Wednesday, Feb. 10, and will explore the cutting edge frontiers of human memory. Washington University in St. Louis scientists are featured in the show.

The Washington University Center for Women’s Infectious Diseases Research held its annual symposium in November on the Medical Campus. The event featured research talks by 2014-15 awardees of the CWIDR Pilot Grant Program, which aims to bring together researchers across departments to focus on topics related to women’s infectious diseases

Over the past seven months, two collaborating teams of scientists at Washington University School of Medicine – both focused on emerging infectious diseases – have redirected their efforts to concentrate on Zika virus.

A new study from Washington University School of Medicine in St. Louis offers strong guidance on the best way to reduce the infection risk. Rather than prepping patients with iodine-alcohol — a common antiseptic combination in C-sections — the research indicates that chlorhexidine-alcohol is significantly more effective.

In real estate, location is key. It now seems the same concept holds true when it comes to stopping pain. New research co-led by the School of Medicine indicates the location of receptors that transmit pain signals is important in how big or small a pain signal will be and how effectively drugs can block those signals.

Engineers at Washington University in St. Louis use nanoparticle technology, applied to a drug found in most people’s medicine cabinets, to chemically alter a cancer tumor and stop its growth.

They look like futuristic eyewear. But the goggles developed by Samuel Achilefu, PhD, and his team at the School of Medicine have a much greater purpose: They help surgeons see and remove cancer. Achilefu discusses his journey from childhood to the development of the goggles, to what he hopes is yet to come.